EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species
EnhancerAtlas 2.0
TagContent
EnhancerAtlas ID
HS051-25361 
Organism
Homo sapiens 
Tissue/cell
Fetal_thymus 
Coordinate
chr7:105330910-105332860 
TF binding sites/motifs
Number: 19             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr7:105332815-105332833CTTTCCTTCCTTCCTTCC-10.53
EWSR1-FLI1MA0149.1chr7:105332819-105332837CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr7:105332823-105332841CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr7:105332827-105332845CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr7:105332831-105332849CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr7:105332835-105332853CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr7:105332839-105332857CCTTCCTTCCTTCCTTCC-10.83
EWSR1-FLI1MA0149.1chr7:105332807-105332825ATTTCTTTCTTTCCTTCC-6.09
EWSR1-FLI1MA0149.1chr7:105332811-105332829CTTTCTTTCCTTCCTTCC-8.46
GFI1MA0038.2chr7:105331662-105331674CCAATCACTGCA+6.44
ZNF263MA0528.1chr7:105332811-105332832CTTTCTTTCCTTCCTTCCTTC-6.03
ZNF263MA0528.1chr7:105331523-105331544CTTCCTCCGTCCCCCTCCCCC-6.1
ZNF263MA0528.1chr7:105332815-105332836CTTTCCTTCCTTCCTTCCTTC-6.48
ZNF263MA0528.1chr7:105332819-105332840CCTTCCTTCCTTCCTTCCTTC-6.94
ZNF263MA0528.1chr7:105332823-105332844CCTTCCTTCCTTCCTTCCTTC-6.94
ZNF263MA0528.1chr7:105332827-105332848CCTTCCTTCCTTCCTTCCTTC-6.94
ZNF263MA0528.1chr7:105332831-105332852CCTTCCTTCCTTCCTTCCTTC-6.94
ZNF263MA0528.1chr7:105332835-105332856CCTTCCTTCCTTCCTTCCTTC-6.94
ZNF263MA0528.1chr7:105332839-105332860CCTTCCTTCCTTCCTTCCTTC-6.94
Number of super-enhancer constituents: 5             
IDCoordinateTissue/cell
SE_15094chr7:105330832-105332912CD4_Memory_Primary_7pool
SE_15641chr7:105330815-105333156CD4_Memory_Primary_8pool
SE_16116chr7:105330884-105333016CD4_Naive_Primary_7pool
SE_16724chr7:105330931-105333071CD4_Naive_Primary_8pool
SE_61779chr7:105313395-105333714Toledo
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr7105332354105332800
Enhancer Sequence
TGGGGGTGGG GTTGGACCCA TCTGTGTGGG ACTCAAGGTC TTGGATCTAA GCAGACCCGC 60
TCCTCAGAAG GCCTTCCGTG AGGCCTAAAT GATGTTTGTC GTCTTCTCCT TCTTTTGCGA 120
TTTGTTTAGT TTAAAATATT TAACCCGAGG CACAATGAAG TGTCTCATTT ACAAGGTTCT 180
CCCGGACCAT TAGACTGGGA CTCCACATTC ATTATGCTGA TGAACGCGCT ACTTACTCAT 240
GCAAATTCCA AGAGCGGCAG ACTCAGAGAT GGGAGGTGCT CAAGGTACGA TATCAAGGGC 300
TGATTTAATT ACACAGCCAT TCAGTGGGAC AAGCACGGCA ATTTTTAGCC AACTGTTCTA 360
GTAAATATTA CGGGAAACCC TTTTATAGAG TGCTAATTCC GGCTTAGTGT TTTCGCTAAG 420
CTTTAGTTCT TACTCAAACA TGCACACGGG CCCCCAAAGA TGCTACCACC AGGCCAGAAA 480
ATCACACAGA TAAAGCATGA GCCCATATGC CATCTTGCAG TCAATCATCC TTTTAAAAAT 540
GTTATAAATG TCTGCATATC ACTGTCATTT AGGTGGGGAC AAACTAAGGT CCAGTAACTT 600
CCCTGTGTCT GTTCTTCCTC CGTCCCCCTC CCCCGTGACT CTGAGTCCTG CAGACCAGCC 660
CTTGGGCATG TTTTGGGTCA CCAAATGCCA CTGCTCCCAG GAGTTTGACA AAACAACCGC 720
TGTAAACTCA TTTCAGACGT TTGAAACAAT ACCCAATCAC TGCATCCACC CTCGAGGAGC 780
GCCCCAGAGG AAATGGCATC ATTACTTTCA TTTTACTCCG TTTGTGAACG ACTAAAGGAA 840
AACAACACGT CCTAGGACTC TCGGGAACGT TATTAAGTGA CCCCTAAGAA ATTAATCATC 900
AAGAGCTAAA ATAACCCTCT GCTGCACATA CACCGCCGTT TCTCTAAGTG GAGAAACAAA 960
TTTCACTTTC CACAGTTGGA ACAGAAACTC TTATGCATCC CCGTTTCTTC AAAAAAAAGT 1020
CTATAAATAA CCTAGGATCA GCAAAATTAT GCAAAACATC CTGCTAGAAG AAGAAATGTA 1080
AACTAAAACC ACTTACAGAG AGACTCAGGC TGCCAACTTA ATCTGATGCT ACGACGACTG 1140
TAAACATGTT GTACTTTTGG AACCTGAAGC GATCCACATT AGCACGGATG TCAGTAAAAA 1200
AAAAAAAAAG AAAAAAAAAA AGAGAGAGAG AGAGAAAGAA AAAGGAGGGA AAAAAATCGC 1260
AACGACTAAA CAACAACAAA AGCCCAGCCC CAAACAGAGC AACGTGATAC GGTATTCTGC 1320
ACGGTGCACA GCCCGACGGC TGACCAGCTG CAGTCAATAC CAGCTATCCG CGCTTGCACA 1380
CGCCAACTGT TTTGACTACA CGCACTTGTT AAACACGGAG TTTCAGGTCC TACCAGTTGG 1440
ACACCAGAAG TTCATAGAAC TGACCCAGTG CCAAGAACAA CAAGCACAGA AAGCGAACCG 1500
GCTGCCTCGT GCGGGTGTTT TTGTTAACTG TTTATGCAAG CCCCAAAGCA ATTGGGTAAC 1560
AATTACGAAT AAAAAAGAAC TTAAATTACA AAAGCAAAAG ATTACCACCT TGAAGGAAAT 1620
GTAGATATTG GCAGCTGAAG GACAGACGTC ATGCTACTTT ATTGGTGGGG TGGGTGGGTA 1680
GTTTTCAGAG AGAACTGGTT GGGGGAGGGG GAGGTGTCAC ATGACACACT GCGGTTATTA 1740
GCAGAAGGAA CTGGGTGCTT CCTCGAAGCA TCTTTTAGAG ATTGACTTAG ATTTTGCAAA 1800
TGTGGAGGCT TTGCTGCACA TGTGGGGGTG ATGGCAGGAG CACTAGAATT TGTCAGTTGG 1860
TAAATCCCAT AGGAGAAGAA AGGGACATGC TGGATGAATT TCTTTCTTTC CTTCCTTCCT 1920
TCCTTCCTTC CTTCCTTCCT TCCTTCCTTC 1950